NTLA
Intellia·NASDAQ
--
--(--)
--
--(--)
NTLA Filings
Filing Date
Form Description
Form Type
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-02
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-02 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-02
Form 8-K - Current report
Key Events
2026-03-02 · Key Events
Form 8-K - Current report
2026-02-26
Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call Transcript
Earnings Call
2026-02-26 · Earnings Call
Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call Transcript
